Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-04-25

Clinical Trial Update: The UCAP 2 Pilot Study [NA]

View source ↗

Summary

The UCAP 2 Pilot Study has been withdrawn from clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: COPD, Asthma | NA | Status: WITHDRAWN